Approval · Notice of Compliance 28779 · 2022
ACET 120: Notice of Compliance 28779
Issued August 18, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28779
- Date
- August 18, 2022
- Company
- Pendopharm Division Of Pharmascience IncMontreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph to comply with the 2020 PM template. Updates to Labelling Materials
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACET 120 | Not yet assigned | — |
| ACET 160 | Not yet assigned | — |
| ACET 325 | Not yet assigned | — |
| ACET 650 | Not yet assigned | — |
Medicinal ingredients
- ACETAMINOPHEN 120 MG per SUP
- ACETAMINOPHEN 160 MG per SUP
- ACETAMINOPHEN 325 MG per SUP
- ACETAMINOPHEN 650 MG per SUP